AB 2122 California Assembly · 2017-2018 Regular Session

Medi-Cal: blood lead screening tests.

Summary
Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law authorizes the department to enter contracts with managed care plans to provide Medi-Cal services. Under existing law, Medi-Cal covers early and periodic screening, diagnosis, and treatment for individuals under 21 years of age, consistent with federal law. Existing law requires the State Department of Public Health to adopt regulations establishing a standard of care under which a child is evaluated for risk of lead poisoning by health care providers during the child's periodic health assessment. This bill would require the State Department of Health Care Services to ensure that a child enrolled in Medi-Cal receives blood lead screening tests at 12 and 24 months of age, or at any time at which the child is identified as having a high risk of lead exposure, as described by the State Department of Public Health, and that a child 2 to 6 years of age, inclusive, receives a blood lead screening test if there is no record of a previous test for that child. The bill would require the department to report its progress toward blood lead screening tests for all enrolled children, as specified, in its annual External Accountability Set as part of the annual external quality review organization review, and annually on its Internet Web site, to ensure Medi-Cal managed care plans make certain each enrolled child receives required blood lead screening tests, and to ensure Medi-Cal managed care plans require health care providers to test enrolled children, as specified. The bill would further require the department to ensure a Medi-Cal managed care plan notifies a child's parent, parents, guardian, or other person charged with his or her support and maintenance, and the child's health care provider, with specified information, including when a child has missed a required blood lead screening test, as specified. The bill would require a contract between the department and a Medi-Cal managed care plan to ensure the plan and its contractors meet the standard of care for early and periodic screening when providing lead testing. This bill would require the State Department of Public Health to prepare provider training guidelines, curriculum, and resources to educate providers about childhood lead poisoning prevention, exposure risks, exposure health effects, and sources of exposure. The bill would require the State Department of Health Care Services to ensure a Medi-Cal managed care plan notifies and educates a contracted health care provider that, for 2 consecutive 12-month periods, fails to blood lead test at least 80% of the enrolled children, as specified, and to ensure that education reflects the training guidelines, curriculum, and resources developed by the State Department of Public Health. The bill would provide that it is the goal of the state that all children at risk of lead exposure receive blood lead screening tests. The bill would also make findings and declarations.
Bill status vetoed 4 of 5 stages cleared
Introduction
Feb 2018
Committee Review
Aug 2018
Assembly Passage
May 2018
Senate Passage
Aug 2018
Vetoed
Sep 2018
Introduced Feb 8, 2018 Vetoed Sep 22, 2018
Floor votes · Senate Aug 23, 2018 · Assembly May 31, 2018

How they voted

35–0
Passed
Total votes 35
Aug 23, 2018
D Democratic24
24 Yea
100% Yea
R Republican11
11 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
30
Key actions
11
Committee
9
Amendments
8
Sep 22, 2018
Vetoed
Vetoed by Governor.
lower
Aug 30, 2018
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 6976.).
lower
Aug 23, 2018
Senate · Passed
Senate Vote: pass (35-0)
senate
Aug 23, 2018
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 25 pursuant to Assembly Rule 77.
lower
Aug 17, 2018
Upper · Passed
From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (August 16).
upper
Aug 6, 2018
Committee
In committee: Referred to APPR. suspense file.
upper
Jul 3, 2018
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Jul 2, 2018
Upper · Passed
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 9. Noes 0.) (June 27).
upper
Jun 14, 2018
Upper · Passed
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
upper
Jun 13, 2018
Committee
Referred to Com. on HEALTH.
upper
May 31, 2018
Assembly · Passed
Assembly Vote: pass (72-0)
assembly
May 25, 2018
Lower · Passed
From committee: Amend, and do pass as amended. (Ayes 12. Noes 0.) (May 25).
lower
May 16, 2018
Committee
In committee: Set, first hearing. Referred to APPR. suspense file.
lower
Apr 25, 2018
Committee
Re-referred to Com. on APPR.
lower
Apr 23, 2018
Lower · Passed
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 17).
lower
Apr 12, 2018
Committee
Re-referred to Com. on HEALTH.
lower
Apr 11, 2018
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
lower
Apr 3, 2018
Lower · Passed
In committee: Hearing postponed by committee.
lower
Feb 22, 2018
Committee
Referred to Com. on HEALTH.
lower
Feb 9, 2018
Lower · Passed
From printer. May be heard in committee March 11.
lower
1 primary · 4 co-sponsors

Sponsors